Related Experiment Video
Updated: Sep 9, 2025

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles
Published on: November 1, 2017
Manipulating anthracyclines for deeper tissue penetration and implications for glycolytic tissues
Erik R Abels1, Esther Ter Linden1, Jos H T Rohling1
1Department of Cell and Chemical Biology and Oncode Institute, Leiden University Medical Center, Leiden 2300 RC, The Netherlands.
Drug penetration into tumors is key for effectiveness. Anthracycline cancer drugs penetrate deeper in acidic tumor conditions, but this may reduce efficacy, suggesting modifications could improve cancer treatment.
Area of Science:
- Pharmacology
- Cancer Biology
- Drug Delivery
Background:
- Drug penetration into target tissues is crucial for therapeutic efficacy.
- Understanding drug diffusion in complex biological environments like tumors remains a challenge.
- Anthracyclines are important chemotherapy agents, but their tissue penetration is not fully understood.
Purpose of the Study:
- To investigate the tissue penetration dynamics of anthracycline cancer drugs.
- To identify physicochemical properties governing drug penetration depth.
- To explore how tumor microenvironment conditions affect drug delivery and efficacy.
Main Methods:
- Utilized a cell-based spheroid model to visualize drug fate using intrinsic fluorescence.
- Examined anthracycline penetration at varying pH conditions, mimicking physiological environments.
- Assessed a library of anthracycline variants to correlate chemical properties with penetration depth.
Main Results:
- Anthracyclines demonstrated intermediate hydrophobicity, penetrating outer cell layers.
- Acidic conditions enhanced spheroid penetration but reduced cell entry and cytotoxicity.
- Molar refractivity, topological polar surface area, and water solubility were key determinants of penetration depth.
Conclusions:
- Tumor microenvironment's acidic and glycolytic conditions may limit anthracycline penetration and contribute to drug resistance.
- Modifying anthracyclines based on identified physicochemical properties could enhance drug delivery to deep-seated tumors.
- This research offers insights for improving anthracycline-based therapies, particularly for challenging targets like pancreatic cancer.
More Related Videos
08:52Intravital Microscopy of Tumor-associated Vasculature Using Advanced Dorsal Skinfold Window Chambers on Transgenic Fluorescent Mice
Published on: January 19, 2018
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...